International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2008 - Hormone Replacement Therapy
View All Articles in Issue

Page(s): 355

Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, chloroxylenol, chlorhexidine diacetate, topical preparations, powder, skin disorders, infection, anti-infective agent, antibiotic

Related Categories: FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder Allen Loyd V Jr	Jul/Aug 2008 Pg. 355
Chlorhexidine Diacetate 2% Topical Gel Allen Loyd V Jr	Sep/Oct 2022 Pg. 424
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
The Basics of Compounding Powders and Granules Allen Loyd V Jr	Jan/Feb 2001 Pg. 36-39
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Acyclovir 5% and Chlorhexidine Diacetate 0.2% Topical Gel Allen Loyd V Jr	Sep/Oct 2004 Pg. 383
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Novel Approaches to Topical Psoriasis Therapy Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin	Sep/Oct 2015 Pg. 357-365
Chlorhexidine 2% Gel Allen Loyd V Jr	Nov/Dec 2007 Pg. 507
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane	Jan/Feb 2017 Pg. 22-27
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations Heustess Allie, Asbill Scott, Eagerton David, Arnold John	Nov/Dec 2014 Pg. 512-515
Chlorhexidine Gel Allen Loyd V Jr	Mar/Apr 2008 Pg. 151
Chlorhexidine and Cetrimide Lotion Allen Loyd V Jr	Jul/Aug 2023 Pg. 316
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Allen Loyd V Jr	Nov/Dec 2016 Pg. 495-500
Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse Allen Loyd V Jr	Mar/Apr 2023 Pg. 148
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice	Mar/Apr 2022 Pg. 150-154
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott	Mar/Apr 2015 Pg. 161-166
Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion Allen Loyd V Jr	May/Jun 2022 Pg. 238
Cyclosporine Topical Gel Formulation Allen Loyd V Jr	Jul/Aug 2023 Pg. 320-321
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Jones Nat, Carvalho Maria, Branvold-Herr Andrea	May/Jun 2017 Pg. 205-211
Return to Top